“…Active bulimia nervosa (BN) sufferers display altered serotonin (5-hydroxytryptamine (5-HT)) system functioning, as evinced by reduced platelet binding of 5-HT uptake inhibitors (Marazziti et al, 1988;Steiger et al, 2000), reduced central 5-HT transporter availability (Tauscher et al, 2001), blunted neuroendocrine responses to 5-HT precursors and agonists (Levitan et al, 1997;Steiger et al, 2001a, b), and decreased 5-HT metabolites in cerebrospinal fluid (Jimerson et al, 1992). As food restriction is known to alter central 5-HT activity in animals (Huether et al, 1997;Zhou et al, 1996) and in humans (Goodwin et al, 1987), abnormal 5-HT function in BN could, reasonably, be a consequence of disordered eating.…”